ACP vs RCP Pilot Study (Aorta Surgery)

Purpose of this Study

We are doing this study to compare measures of brain function after surgical circulatory arrest ( when the surgeon stops the heart-lung machine to work on your heart) in antegrade perfusion versus retrograde perfusion. Antegrade and retrograde perfusion are 2 different ways to supply blood to the brain during this type of surgery. In antegrade perfusion, the surgeon accesses one of two arteries that branch off from the aorta (the artery that delivers blood to the rest of the body) to provide blood to the brain. In retrograde perfusion, the surgeon accesses the superior vena cava (large vein bringing blood back to the heart) to supply blood to the brain. Both methods are commonly used, but we want to find out if one method works better for most people than the other.

Who Can Participate?

Eligibility

Adults ages 18+ who:
  • Are scheduled for elective surgery on the aorta
  • Will undergo a surgery that uses very cold temperatures and circulatory arrest (surgeon stops the heart-lung machine to work on your heart)
  • Do not have more than 2 drinks per day of alcohol
  • Have no history of chronic neurological damage from a stroke
For more information, contact the study team at kelly.rodden@duke.edu.

Age Range

19-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

If you choose to join this study, you will get a random assignment (like a coin flip) to have either antegrade or retrograde perfusion done during your surgery. You will have blood draws and MRI imaging done before and after your surgery as a way to collect information about your brain's function.

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Retrograde vs Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery

Principal Investigator

Joseph
Mathew

Protocol Number

PRO00116844

NCT ID

NCT06986967

Phase

Pilot

Enrollment Status

Open to Enrollment